Arena Pharmaceuticals, Inc. Operating Lease, Expense
Arena Pharmaceuticals, Inc. reported Operating Lease, Expense of $2.40 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-02-23
- Arena Pharmaceuticals, Inc. operating lease, expense for fiscal 2021 was $2.40M, a 0.00% change from fiscal 2020.
- Arena Pharmaceuticals, Inc. operating lease, expense for fiscal 2020 was $2.40M, a 26.32% increase from fiscal 2019.
- Arena Pharmaceuticals, Inc. operating lease, expense for fiscal 2019 was $1.90M.
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2021-12-31 | $2.40M 10-K · filed 2022-02-23 |
| 2020-12-31 | $2.40M 10-K · filed 2022-02-23 |
| 2019-12-31 | $1.90M 10-K · filed 2022-02-23 |